Key facts about Dacomitinib
What dosages is Dacomitinib available in?
Dacomitinib is available as a 15 mg, 30 mg, and 45 mg oral tablet.
What is Dacomitinib used for?
Dacomitinib is a kinase inhibitor that is used to treat metastatic non-small cell lung cancer (NSCLC) with changes in the EGFR gene.
How does Dacomitinib work?
Dacomitinib is a kinase inhibitor. It targets EGFR proteins made by these mutated EGFR genes. When EGFR is blocked by Dacomitinib, the cancer cells can’t grow and spread as well.
How do I take Dacomitinib?
Dacomitinib is typically taken as 45 mg by mouth once daily.
Is it safe for me to take Dacomitinib?
Dacomitinib is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Dacomitinib Common Side Effects
Common side effects of Dacomitinib:
- Diarrhea
- Rash
- Nail infection
- Painful sores inside the mouth and throat
- Low red and white blood cell counts
- Low albumin levels
- Higher liver enzyme levels
- High blood sugar
- Low electrolyte levels
- Loss of appetite
- Dry skin
- Weight loss
- Hair loss
- Itchy skin
- Cough
Dacomitinib Serious Side Effects
Serious side effects are rare with Dacomitinib. Contact your healthcare provider immediately if you experience any of the following.
- Serious lung problems: dry cough, fever, trouble breathing, fast or shallow breathing, chest pain
Severe diarrhea
Effects of other drugs, drug classes and over-the-counter products on Dacomitinib
The following medications may interact with Dacomitinib:
- Proton Pump Inhibitors (PPIs): Avoid use with Dacomitinib; use locally-acting antacids or H2-receptor antagonist; administer Dacomitinib at least 6 hours before or 10 hours after H2-receptor antagonist
- CYP2D6 Substrates: Avoid concomitant use with Dacomitinib where minimal increases in concentration of the CYP2D6 substrate may lead to serious or life-threatening toxicities
Who makes Dacomitinib?
Various FDA-approved generic manufacturers
Is Dacomitinib safe in pregnancy?
Dacomitinib can harm your unborn baby. Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with Dacomitinib
- You should use effective birth control (contraception) during treatment and for at least 17 days after your last dose of Dacomitinib. Talk to your healthcare provider about birth control methods that may be right for you during this time
- Tell your healthcare provider right away if you become pregnant during your treatment with Dacomitinib
